These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 30455692

  • 1. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B, Liu J, Meng T, Li Y, He D, Ran X, Chen G, Guo W, Kan X, Fu S, Wang W, Liu D.
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [Abstract] [Full Text] [Related]

  • 2. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G.
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [Abstract] [Full Text] [Related]

  • 3. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X, Liu DF, Zhang XY, Liu D, Xu SY, Chen GX, Huang BX, Ren WZ, Wang W, Fu SP, Liu JX.
    Int J Mol Sci; 2017 Feb 12; 18(2):. PubMed ID: 28208679
    [Abstract] [Full Text] [Related]

  • 4. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G, Liu J, Jiang L, Ran X, He D, Li Y, Huang B, Wang W, Liu D, Fu S.
    Int J Mol Sci; 2018 Mar 12; 19(3):. PubMed ID: 29534526
    [Abstract] [Full Text] [Related]

  • 5. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G, Liu J, Jiang L, Ran X, He D, Li Y, Huang B, Wang W, Fu S.
    Int J Mol Sci; 2017 Dec 21; 19(1):. PubMed ID: 29267220
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L, Zhang X, Li X, Liu N, Lou F, Ma H, Luo X, Ren Y.
    Mol Med Rep; 2015 Jul 21; 12(1):1002-8. PubMed ID: 25777539
    [Abstract] [Full Text] [Related]

  • 7. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease.
    Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX.
    Oxid Med Cell Longev; 2020 Jul 21; 2020():4754195. PubMed ID: 32963694
    [Abstract] [Full Text] [Related]

  • 8. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL, Hsu JY, Chen TC, Huang CC, Wu TY, Chin TY.
    Int J Mol Sci; 2022 Jan 12; 23(2):. PubMed ID: 35054997
    [Abstract] [Full Text] [Related]

  • 9. Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects via Activating AKT/Nrf2/HO-1 and Inhibiting NF-κB Pathways In Vivo and In Vitro.
    He D, Fu S, Zhou A, Su Y, Gao X, Zhang Y, Huang B, Du J, Liu D.
    Front Immunol; 2021 Jan 12; 12():619761. PubMed ID: 33868235
    [Abstract] [Full Text] [Related]

  • 10. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B, Liu J, Ju C, Yang D, Chen G, Xu S, Zeng Y, Yan X, Wang W, Liu D, Fu S.
    Int J Mol Sci; 2017 Sep 22; 18(10):. PubMed ID: 28937602
    [Abstract] [Full Text] [Related]

  • 11. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW, Koppula S, Kumar H, Park JY, Kim IW, More SV, Kim IS, Han SD, Kim SK, Yoon SH, Choi DK.
    Neuropharmacology; 2015 Oct 22; 97():46-57. PubMed ID: 25983275
    [Abstract] [Full Text] [Related]

  • 12. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
    He D, Huang B, Fu S, Li Y, Ran X, Liu Y, Chen G, Liu J, Liu D.
    Int J Mol Sci; 2018 Jul 31; 19(8):. PubMed ID: 30065205
    [Abstract] [Full Text] [Related]

  • 13. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z, Shen C, Li H, Tong J, Wu Y, Ma Y, Wang J, Wang Z, Li Q, Zhang X, Dong H, Yang Y, Yu M, Wang J, Zhou R, Fei J, Huang F.
    J Neuroinflammation; 2023 Apr 18; 20(1):96. PubMed ID: 37072793
    [Abstract] [Full Text] [Related]

  • 14. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model.
    Arab HH, Safar MM, Shahin NN.
    ACS Chem Neurosci; 2021 Feb 17; 12(4):689-703. PubMed ID: 33543924
    [Abstract] [Full Text] [Related]

  • 15. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.
    Huang B, Hu G, Zong X, Yang S, He D, Gao X, Liu D.
    Int Immunopharmacol; 2023 Feb 17; 115():109698. PubMed ID: 36634417
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A.
    Neurobiol Dis; 2016 Sep 17; 93():96-114. PubMed ID: 27151770
    [Abstract] [Full Text] [Related]

  • 17. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D, Fu S, Ye B, Wang H, He Y, Li Z, Li J, Gao X, Liu D.
    J Neuroinflammation; 2023 Mar 29; 20(1):86. PubMed ID: 36991440
    [Abstract] [Full Text] [Related]

  • 18. Mesencephalic astrocyte-derived neurotrophic factor (MANF) prevents the neuroinflammation induced dopaminergic neurodegeneration.
    Zhang JX, Zhou KG, Yin YX, Jin LJ, Tong WF, Guo J, Yu LH, Ye XC, Jiang M.
    Exp Gerontol; 2023 Jan 29; 171():112037. PubMed ID: 36436758
    [Abstract] [Full Text] [Related]

  • 19. Evodiamine Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in BV-2 Cells via Regulating AKT/Nrf2-HO-1/NF-κB Signaling Axis.
    Meng T, Fu S, He D, Hu G, Gao X, Zhang Y, Huang B, Du J, Zhou A, Su Y, Liu D.
    Cell Mol Neurobiol; 2021 Jan 29; 41(1):115-127. PubMed ID: 32279133
    [Abstract] [Full Text] [Related]

  • 20. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N, Sharma S, Nehru B.
    Inflammopharmacology; 2017 Jun 29; 25(3):351-368. PubMed ID: 28409389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.